425 related articles for article (PubMed ID: 19923096)
1. [Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease].
Hagymási K; Reismann P; Rácz K; Tulassay Z
Orv Hetil; 2009 Nov; 150(48):2173-81. PubMed ID: 19923096
[TBL] [Abstract][Full Text] [Related]
2. Endocrine and liver interaction: the role of endocrine pathways in NASH.
Loria P; Carulli L; Bertolotti M; Lonardo A
Nat Rev Gastroenterol Hepatol; 2009 Apr; 6(4):236-47. PubMed ID: 19347015
[TBL] [Abstract][Full Text] [Related]
3. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.
Baranova A; Tran TP; Birerdinc A; Younossi ZM
Aliment Pharmacol Ther; 2011 Apr; 33(7):801-14. PubMed ID: 21251033
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women.
Rodrigues MH; Bruno AS; Nahas-Neto J; Santos ME; Nahas EA
Gynecol Endocrinol; 2014 May; 30(5):325-9. PubMed ID: 24460502
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease.
Tarantino G; Finelli C
World J Gastroenterol; 2013 Oct; 19(40):6735-43. PubMed ID: 24187449
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic steatohepatitis and metabolic syndrome.
Machado M; Cortez-Pinto H
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
[TBL] [Abstract][Full Text] [Related]
7. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643
[TBL] [Abstract][Full Text] [Related]
8. [Adipocitokines and nonalcoholic steatohepatitis].
Lăcătuşu C; Mihai B; Cijevschi-Prelipcean C; Mihai C; Graur M
Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):882-9. PubMed ID: 20209757
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology, pathogenesis and histopathology of fatty liver disease.
Levene AP; Goldin RD
Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
[TBL] [Abstract][Full Text] [Related]
10. Endocrine testing in obesity.
Wilding JPH
Eur J Endocrinol; 2020 Apr; 182(4):C13-C15. PubMed ID: 32061161
[TBL] [Abstract][Full Text] [Related]
11. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
12. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
Ságodi L; Lombay B; Vámosi I; Barkai L
Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
[TBL] [Abstract][Full Text] [Related]
13. Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: do androgens play a role?
Kauffman RP; Baker TE; Baker V; Kauffman MM; Castracane VD
Gynecol Endocrinol; 2010 Jan; 26(1):39-46. PubMed ID: 20001571
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of steatosis in nonalcoholic fatty liver disease.
Pettinelli P; Obregón AM; Videla LA
Nutr Hosp; 2011; 26(3):441-50. PubMed ID: 21892559
[TBL] [Abstract][Full Text] [Related]
15. The metabolic syndrome and nonalcoholic fatty liver disease.
Collantes RS; Ong JP; Younossi ZM
Panminerva Med; 2006 Mar; 48(1):41-8. PubMed ID: 16633331
[TBL] [Abstract][Full Text] [Related]
16. Liver abnormalities and endocrine diseases.
Burra P
Best Pract Res Clin Gastroenterol; 2013 Aug; 27(4):553-63. PubMed ID: 24090942
[TBL] [Abstract][Full Text] [Related]
17. The impact of obesity and metabolic syndrome on chronic hepatitis C.
Goossens N; Negro F
Clin Liver Dis; 2014 Feb; 18(1):147-56. PubMed ID: 24274870
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
Tarantino G; Saldalamacchia G; Conca P; Arena A
J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757
[TBL] [Abstract][Full Text] [Related]
19. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
Yki-Järvinen H
Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
[TBL] [Abstract][Full Text] [Related]
20. PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis?
Doi SA; Towers PA; Scott CJ; Al-Shoumer KA
Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):4-16. PubMed ID: 15596265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
